Preview

Остеопороз и остеопатии

Расширенный поиск

СОСТОЯНИЕ МИНЕРАЛЬНОЙ ПЛОТНОСТИ КОСТНОЙ ТКАНИ И КОСТНОГО МЕТАБОЛИЗМА ПРИ СИНДРОМЕ ШЕРЕШЕВСКОГО - ТЕРНЕРА Обзор литературы

https://doi.org/10.14341/osteo2005244-48

Полный текст:

Список литературы

1. Apter D., Lenko H.L., Perheentupa J. et al. Subnormal pubertal increases of serum androgens in Turner's syndrome // Horm. Res. 198. Vol. 216. P. 164-173.

2. Bergmann P., Valsamis J., Van Perborgh J. et al. Comparative study of the changes in insulin-like growth factor-1, procollagen-III N-terminal extension peptide, bone gla-protein and bone mineral content in children with Turner syndrome treated with recombinant growth hormone // J. Clin. Endocrinol. Metab. 1990. Vol.71.: P. 1461-1467.

3. Bertelloni S., Cinquanta L., Baroncelli G.I. et al..Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone // Horm. Res. 2000. Vol. 53. N2. P. 72-76.

4. Boot A.M., de Ridder M.A., Pols H.A. et al. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity // J. Clin. Endocrinol. Metab. 1997. Vol. 82. P. 57-62.

5. Breuil V., Euller-Ziegler L. Gonadal dysgenesis and bone metabolism // Joint Bone Spine. 2001. Vol. 68. N1. P. 26-33.

6. Buchanan J.R., Myers C., Lloyd T. et al. Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise // J. Bone Miner. Res. 1988. Vol. 3. P. 673-680.

7. Carrascosa A., Gussinye M., Terradas P. et al. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients // J. Bone Miner. Res. 2000. Vol. 15. P. 2005-2010.

8. Carrel L., Cottle A.A., Goglin K.C., Willard H.F. A first-generation X-inactivation profile of the human X chromosome // Proc. Natl. Acad. Sci. USA. 1999. Vol. 96. P.14440-14444.

9. Clement-Jones M., Schiller S., Rao E. et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome // Hum. Mol. Genet. 2000. Vol. 9. P.695-702.

10. Davies M.C., Gulekli B., Jacobs H.S. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea // Clin. Endocrinol. (Oxf). 1995. Vol. 43. P. 741-746

11. Ellison J.W., Wardak Z., Young M.F. et al. PHOG, a candidate gene for involvement in the short stature of Turner syndrome // Hum. Mol. Genet. 1997. Vol. 6. P. 1341-1347.

12. Elsheikh M., Dunger D. B., Conway G. S., and Wass J. A. H. Turner's Syndrome in Adulthood // Endocr. Rev. 2002. Vol.23. N1. P. 120-140.

13. Emans S.J. Grace E., Hoffer F.A. et al. Estrogen deficiency in adolescents and young adults: impact on bone mineral content and effects of estrogen replacement therapy // Obstet. Gynecol. 1990. Vol.76. P. 585-592.

14. Ferguson-Smith M.A. Karyotype-phenotype correlation in gonadal dysgenesis and their hearing on the pathogenesis of malformation // J. Med. Genet. 1965. Vol.2. P. 142-155.

15. Garden A.S., Diver M.J., Fraser W.D. Undiagnosed morbidity in adult women with Turner's syndrome // Clin. Endocrinol. (Oxf). 1996. Vol.45. P. 589-593.

16. Gravholt C.H., Lauridsen A.L., Brixen K. et al. Marked Disproportionality in Bone Size and Mineral, and Distinct Abnormalities in Bone Markers and Calcitropic Hormones in Adult Turner Syndrome: A Cross-Sectional Study // J. Clin. Endocrinol. Metab. 1999. Vol. 87. N6. P. 2798-2808.

17. Gravholt C.H., Fedder J., Naeraa R.W., Müller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material-a population study // J. Clin. Endocrinol. Metab. 2000. Vol.85. P. 3199-3202.

18. Gravholt C.H., Frystyk J., Flyvbjerg A. et al. Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids // Am. J. Physiol. 2001. Vol. 280. E308-E314.

19. Gravholt C.H., Juul S., Naeraa R.W., Hansen J. Morbidity in Turner syndrome // J. Clin. Epidemiol. 1998. Vol. 51. P. 147-158.

20. Gravholt C.H., Naeraa R.W. Reference values for body proportions and body composition in adult women with Turner's syndrome // Am. J. Med. Genet. 1997. Vol.72. P.403-408.

21. Guarneri M.P., Abusrewil S.A., Bernasconi S. et al. Turner's syndrome // Pediatr. Endocrinol. Metab. 2001. Vol.14. Suppl. 2. P. 959-965.

22. Haber H.P., Ranke M.B. Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume // J. Ultrasound. Med. 1999. Vol.18. P.271-276.

23. Hochberg Z., Aviram M., Rubin D., Pollack S. Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes // Eur. J. Clin. Invest. 1997. Vol. 27. P. 543-547.

24. Holl R.W., Kunze D., Etzrodt H. et al. Turner syndrome: final height, glucose tolerance, bone density and psychosocial status in 25 adult patients // Eur. J. Pediatr. 1994. Vol.153. P. 11-16.

25. Hreinsson J. G., Otala M., Fridstrom M., et al. Follicles Are Found in the Ovaries of Adolescent Girls with Turner's Syndrome // J. Clin. Endocrinol. Metab. 2002. Vol. 87. N8. P. 3618-3623.

26. Inzucchi S.E., Robbins R.J. Clinical review 61: effects of growth hormone on human bone biology // J. Clin. Endocrinol. Metab. 1994. Vol. 79. P. 691-694.

27. Kosho T., Muroya K., Nagai T. et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome // J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 4613-4621.

28. Kurabayashi T., Yasuda M., Fujimaki T. et al. Effect of hormone replacement therapy on spinal bone mineral density and T lymphocyte subsets in premature ovarian failure and Turner's syndrome // Int. J. Gynaecol. Obstet. 1993. Vol. 42. P. 25-31.

29. Landin-Wilhelmsen K., Bryman I., Windh M., Wilhelmsen L. Osteoporosis and fractures in Turner syndrome: importance of growth promoting and oestrogen therapy // Clin. Endocrinol. (Oxf). 1999. Vol. 51. P. 497-502.

30. Lanes R., Gunczler P., Paoli M., Weisinger J.R. Bone mineral density of prepubertal age girls with Turner's syndrome while on growth hormone therapy // Horm. Res. 1995. Vol. 44. N4. P. 168-171.

31. Lubin M.B., Gruber H.E., Rimoin D.L., Lachman R.S. Skeletal abnormalities in the Turner syndrome. In: Rosenfeld RG, Grumbach MM, eds. Turner syndrome. New York: Marcel Dekker. 1990. P. 281-300.

32. Lyon A.J., Preece M.A., Grant D.B. Growth curve for girls with Turner syndrome // Arch. Dis. Child. 1985. Vol. 60. P. 932-935.

33. Massarano A.A., Adams J.A., Preece M.A., Brook C.G. Ovarian ultrasound appearances in Turner syndrome // J. Pediatr. 1989. Vol. 114. P. 568-573.

34. Mauras N., Vieira N.E., Yergey A.L. Estrogen therapy enhances calcium absorption and retention and diminishes bone turnover in young girls with Turner's syndrome: a calcium kinetic study // Metabolism. 1997. Vol. 46. P. 908-913.

35. Mora S., Weber G., Guarneri M.P. et al. Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome // Obstet. Gynecol. 1992. Vol.79. P. 747-751.

36. Mullis P.E., Yoshimura N., Kuhlmann B., et al. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood // J. Clin. Endocrinol. Metab. 1997. Vol.82. P. 1739-1745.

37. Naeraa R.W., Brixen K., Hansen R.M. et al. Skeletal size and bone mineral content in Turner's syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover // Calcif. Tissue Int. 1991. Vol. 49. P. 77-83.

38. Naeraa R.W., Gravholt C.H, Hansen J., et al. Mortality in Turner syndrome. In: Albertsson-Wikland K, Ranke MB, eds. Turner syndrome in a lifespan perspective: research and clinical aspects. Amsterdam: Elsevier; 1995. P. 323.

39. Neely E.K., Marcus R., Rosenfeld R.G., Bachrach L.K. Turner syndrome adolescents receiving growth hormone are not osteopenic // J. Clin. Endocrinol. Metab. 1993. Vol. 76. P. 861-866.

40. Norman A.W., Bishop J.E., Collins E.D. et al. Differing shapes of 1,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report // J. Steroid. Biochem. Mol. Biol. 1996. Vol. 56. P. 13-22.

41. Ogata T., Matsuo N., Nishimura G. SHOX haploinsufficiency and overdosage: impact of gonadal function status // J. Med. Genet. 2001. Vol. 138. P. 1-6.

42. Pors Nielsen S., Kolthoff N., Barenholdt O. et al. Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded? // Br. J. Radiol. 1998. Vol. 71. P.934-943.

43. Prior J.C., Vigna Y.M., Wark J.D. et al. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate // J. Bone Miner. Res. 1997. Vol.12. P.1851-1863.

44. Ranke M.B., Pfluger H., Rosendahl W., et al. Turner syndrome: spontaneous growth in 150 cases and review of the literature // Eur. J. Pediatr. 1983. Vol. 141. P. 81-88.

45. Ranke M.B., Saenger P. Turner's syndrome // Lancet. 2001. Vol. 358. N 9278. P. 309-314.

46. Rao E., Weiss B., Fukami M., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome // Nat. Genet. 1997. Vol. 16. P. 54-63.

47. Rao E., Weiss B., Fukami M., et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome // Nat. Genet. 1997. Vol. 16. P. 54-63.

48. Ross J.L., Long L.M., Feuillan P. et al. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome // J. Clin. Endocrinol. Metab. 1991. Vol.73. P. 355-359.

49. Ruiz C., Lamm F., Hart P.S. Turner syndrome and multiple-marker screening // Clin. Chem. 1999. Vol. 945. P. 2259-2261.

50. Saenger P. Turner's syndrome // N. Engl. J. Med. 1996. Vol.335. P. 1749-1754.

51. Saenger P., Wikland K.A., Conway G.S. Recommendations for the Diagnosis and Management of Turner Syndrome // J. Clin. Endocrinol. Metab. 2001. Vol. 86. N 7. P. 3061-3069.

52. Saggese G., Federico G., Bertelloni S., Baroncelli G.I. Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function // J. Clin. Endocrinol. Metab. 1992. Vol. 75. P. 998-1001.

53. Sass T.C., De Muinck Keizer-Schrama S.M., Stijnen T. et al. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial // Clin. Endocrinol. (Oxf.). 2000. Vol. 52. P. 531-536.

54. Sass T.C.J., de Muinck Keizer-Schrama S. M. P. F., Stijnen T. et al. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study // J. Clin. Endocrinol. Metab. 2000. Vol. 85. N 2. P. 769-775.

55. Schmitt K., Haeusler G., Blьmel P., et al. Short and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype // Horm. Res. 1997. Vol. 47. P. 67-72.

56. Shore R.M., Chesney R.W., Mazess R.B. et al. Skeletal demineralization in Turner's syndrome // Calcif. Tissue Int. 1982. Vol. 34. P. 519-522.

57. Slemenda C., Longcope C., Peacock M. et al. Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri- and postmenopausal women // J. Clin. Invest. 1996. Vol. 97. P. 14-21.

58. Smith M.A., Wilson J., Price W.H. Bone demineralisation in patients with Turner's syndrome // J. Med. Genet. 1982. Vol. 19. P. 100-103.

59. Stepan J.J., Musilova J., Pacovsky V. Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome // J. Bone Miner. Res. 1989. Vol. 4. P. 193-198.

60. Sylven L., Hagenfeldt K., Ringertz H. Bone mineral density in middle-aged women with Turner's syndrome // Eur. J. Endocrinol. 1995. Vol. 132. P. 47-52.

61. Taback S.P., Deal C., Van Vliet G. Turner's syndrome // N. Engl. J. Med. 1997. Vol. 336. N 21. P. 1527; author reply 1527-1528.

62. Theintz G., Buchs B., Rizzoli R. et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects // J. Clin. Endocrinol. Metab. 1992. Vol. 75. P. 1060-1065.

63. Vaananen H.K., Harkonen P.L. Estrogen and bone metabolism. Maturitas 23 (Suppl). 1996. S. 65-S. 69.

64. Vestergaard P., Hermann A.P., Orskov H., Mosekilde L. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study // J. Clin. Endocrinol. Metab. 1999. Vol. 84. P. 2286-2290.

65. Weiss L. Additional evidence of gradual loss of germ cells in the pathogenesis of streak ovaries in Turner's syndrome // J. Med. Genet. 1971. Vol. 8. P. 540-544.


Рецензия

Для цитирования:


., ., . СОСТОЯНИЕ МИНЕРАЛЬНОЙ ПЛОТНОСТИ КОСТНОЙ ТКАНИ И КОСТНОГО МЕТАБОЛИЗМА ПРИ СИНДРОМЕ ШЕРЕШЕВСКОГО - ТЕРНЕРА Обзор литературы. Остеопороз и остеопатии. 2005;8(2):44-48. https://doi.org/10.14341/osteo2005244-48

For citation:


DRAGUN S.A., SEMIChEVA T.V., ANDREEVA E.N. SOSTOYaNIE MINERAL'NOY PLOTNOSTI KOSTNOY TKANI I KOSTNOGO METABOLIZMA PRI SINDROME ShEREShEVSKOGO - TERNERA Obzor literatury. Osteoporosis and Bone Diseases. 2005;8(2):44-48. (In Russ.) https://doi.org/10.14341/osteo2005244-48

Просмотров: 103


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)